lenalidomide has been researched along with Lupus Erythematosus, Chronic Cutaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardis, MA; Kirkorian, AY; Sherman, MA; Srinivasalu, H | 1 |
| Albrecht, J; Bonilla-Martinez, Z; Okawa, J; Rose, M; Rosenbach, M; Shah, A; Werth, VP | 1 |
2 other study(ies) available for lenalidomide and Lupus Erythematosus, Chronic Cutaneous
| Article | Year |
|---|---|
Clinical Images: Chronic, refractory childhood-onset cutaneous lupus erythematosus of the face responsive to lenalidomide.
Topics: Child; Humans; Lenalidomide; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Thalidomide | 2023 |
Lenalidomide for the treatment of resistant discoid lupus erythematosus.
Topics: Adult; Female; Humans; Lenalidomide; Lupus Erythematosus, Discoid; Neutropenia; Thalidomide | 2009 |